US 12269831
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K45/06
Quick answer
US patent 12269831 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K45/06